Bahmanyar S - Search Results

1

Transition states of amine-catalyzed aldol reactions involving enamine intermediates: theoretical studies of mechanism, reactivity, and stereoselectivity.

Bahmanyar S, Houk KN. Bahmanyar S, et al. J Am Chem Soc. 2001 Nov 14;123(45):11273-83. doi: 10.1021/ja011403h. J Am Chem Soc. 2001. PMID: 11697970

2

The origin of stereoselectivity in proline-catalyzed intramolecular aldol reactions.

Bahmanyar S, Houk KN. Bahmanyar S, et al. J Am Chem Soc. 2001 Dec 26;123(51):12911-2. doi: 10.1021/ja011714s. J Am Chem Soc. 2001. PMID: 11749554 No abstract available.

3

Kinetic and stereochemical evidence for the involvement of only one proline molecule in the transition states of proline-catalyzed intra- and intermolecular aldol reactions.

Hoang L, Bahmanyar S, Houk KN, List B. Hoang L, et al. Among authors: bahmanyar s. J Am Chem Soc. 2003 Jan 8;125(1):16-7. doi: 10.1021/ja028634o. J Am Chem Soc. 2003. PMID: 12515489

4

Quantum mechanical predictions of the stereoselectivities of proline-catalyzed asymmetric intermolecular aldol reactions.

Bahmanyar S, Houk KN, Martin HJ, List B. Bahmanyar S, et al. J Am Chem Soc. 2003 Mar 5;125(9):2475-9. doi: 10.1021/ja028812d. J Am Chem Soc. 2003. PMID: 12603135

5

Origins of opposite absolute stereoselectivities in proline-catalyzed direct Mannich and aldol reactions.

Bahmanyar S, Houk KN. Bahmanyar S, et al. Org Lett. 2003 Apr 17;5(8):1249-51. doi: 10.1021/ol034198e. Org Lett. 2003. PMID: 12688731

6

Crystal structures of orotidine monophosphate decarboxylase: does the structure reveal the mechanism of nature's most proficient enzyme?

Houk KN, Lee JK, Tantillo DJ, Bahmanyar S, Hietbrink BN. Houk KN, et al. Among authors: bahmanyar s. Chembiochem. 2001 Feb 2;2(2):113-8. doi: 10.1002/1439-7633(20010202)2:2<113::AID-CBIC113>3.0.CO;2-T. Chembiochem. 2001. PMID: 11828434 No abstract available.

7

Proximity effects in the palladium-catalyzed substitution of aryl fluorides.

Bahmanyar S, Borer BC, Kim YM, Kurtz DM, Yu S. Bahmanyar S, et al. Org Lett. 2005 Mar 17;7(6):1011-4. doi: 10.1021/ol047413f. Org Lett. 2005. PMID: 15760126

8

Fluorination-free synthesis of a 4,4-difluoro-3,3-dimethylproline derivative.

Chen L, Kim YM, Kucera DJ, Harrison KE, Bahmanyar S, Scott JM, Yazbeck D. Chen L, et al. Among authors: bahmanyar s. J Org Chem. 2006 Jul 21;71(15):5468-73. doi: 10.1021/jo060057p. J Org Chem. 2006. PMID: 16839124

9

Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223.

Mortensen DS, Perrin-Ninkovic SM, Shevlin G, Zhao J, Packard G, Bahmanyar S, Correa M, Elsner J, Harris R, Lee BG, Papa P, Parnes JS, Riggs JR, Sapienza J, Tehrani L, Whitefield B, Apuy J, Bisonette RR, Gamez JC, Hickman M, Khambatta G, Leisten J, Peng SX, Richardson SJ, Cathers BE, Canan SS, Moghaddam MF, Raymon HK, Worland P, Narla RK, Fultz KE, Sankar S. Mortensen DS, et al. Among authors: bahmanyar s. J Med Chem. 2015 Jul 9;58(13):5323-33. doi: 10.1021/acs.jmedchem.5b00626. Epub 2015 Jun 26. J Med Chem. 2015. PMID: 26083478

10

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.

Riggs JR, Nagy M, Elsner J, Erdman P, Cashion D, Robinson D, Harris R, Huang D, Tehrani L, Deyanat-Yazdi G, Narla RK, Peng X, Tran T, Barnes L, Miller T, Katz J, Tang Y, Chen M, Moghaddam MF, Bahmanyar S, Pagarigan B, Delker S, LeBrun L, Chamberlain PP, Calabrese A, Canan SS, Leftheris K, Zhu D, Boylan JF. Riggs JR, et al. Among authors: bahmanyar s. J Med Chem. 2017 Nov 9;60(21):8989-9002. doi: 10.1021/acs.jmedchem.7b01223. Epub 2017 Oct 27. J Med Chem. 2017. PMID: 28991472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters